105 related articles for article (PubMed ID: 15916486)
1. Adenovirus-mediated silencing of huntingtin expression by shRNA.
Huang B; Kochanek S
Hum Gene Ther; 2005 May; 16(5):618-26. PubMed ID: 15916486
[TBL] [Abstract][Full Text] [Related]
2. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo.
Huang B; Schiefer J; Sass C; Landwehrmeyer GB; Kosinski CM; Kochanek S
Hum Gene Ther; 2007 Apr; 18(4):303-11. PubMed ID: 17472569
[TBL] [Abstract][Full Text] [Related]
3. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
[TBL] [Abstract][Full Text] [Related]
4. Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range.
Majumder P; Raychaudhuri S; Chattopadhyay B; Bhattacharyya NP
Cell Mol Neurobiol; 2007 Dec; 27(8):1127-45. PubMed ID: 17902043
[TBL] [Abstract][Full Text] [Related]
5. Antisense downregulation of mutant huntingtin in a cell model.
Hasholt L; Abell K; Nørremølle A; Nellemann C; Fenger K; Sørensen SA
J Gene Med; 2003 Jun; 5(6):528-38. PubMed ID: 12797118
[TBL] [Abstract][Full Text] [Related]
6. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin.
Olson SD; Kambal A; Pollock K; Mitchell GM; Stewart H; Kalomoiris S; Cary W; Nacey C; Pepper K; Nolta JA
Mol Cell Neurosci; 2012 Mar; 49(3):271-81. PubMed ID: 22198539
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 receptor-mediated aggregation of N-terminal fragments of mutant huntingtin and cell death in a neuroblastoma cell line.
Robinson P; Lebel M; Cyr M
Neuroscience; 2008 May; 153(3):762-72. PubMed ID: 18403126
[TBL] [Abstract][Full Text] [Related]
8. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
[TBL] [Abstract][Full Text] [Related]
9. AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.
Franich NR; Fitzsimons HL; Fong DM; Klugmann M; During MJ; Young D
Mol Ther; 2008 May; 16(5):947-56. PubMed ID: 18388917
[TBL] [Abstract][Full Text] [Related]
10. Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington's disease gene.
Tanaka K; Shouguchi-Miyata J; Miyamoto N; Ikeda JE
J Biol Chem; 2004 Feb; 279(8):7275-86. PubMed ID: 14625278
[TBL] [Abstract][Full Text] [Related]
11. Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates.
Fukui H; Moraes CT
Hum Mol Genet; 2007 Apr; 16(7):783-97. PubMed ID: 17356014
[TBL] [Abstract][Full Text] [Related]
12. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.
Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E
PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888
[TBL] [Abstract][Full Text] [Related]
13. Distinct aggregation and cell death patterns among different types of primary neurons induced by mutant huntingtin protein.
Tagawa K; Hoshino M; Okuda T; Ueda H; Hayashi H; Engemann S; Okado H; Ichikawa M; Wanker EE; Okazawa H
J Neurochem; 2004 May; 89(4):974-87. PubMed ID: 15140196
[TBL] [Abstract][Full Text] [Related]
14. Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference.
Chen ZJ; Kren BT; Wong PY; Low WC; Steer CJ
Biochem Biophys Res Commun; 2005 Apr; 329(2):646-52. PubMed ID: 15737634
[TBL] [Abstract][Full Text] [Related]
15. Replacement of huntingtin exon 1 by trans-splicing.
Rindt H; Yen PF; Thebeau CN; Peterson TS; Weisman GA; Lorson CL
Cell Mol Life Sci; 2012 Dec; 69(24):4191-204. PubMed ID: 22814437
[TBL] [Abstract][Full Text] [Related]
16. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
Hazeki N; Nakamura K; Goto J; Kanazawa I
Biochem Biophys Res Commun; 1999 Mar; 256(2):361-6. PubMed ID: 10079189
[TBL] [Abstract][Full Text] [Related]
17. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
[TBL] [Abstract][Full Text] [Related]
18. High efficiency adenovirus-mediated expression of truncated N-terminal huntingtin fragment (htt552) in primary rat astrocytes.
Wang L; Lin F; Wu J; Qin Z
Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):325-34. PubMed ID: 19352548
[TBL] [Abstract][Full Text] [Related]
19. Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease.
Skogen M; Roth J; Yerkes S; Parekh-Olmedo H; Kmiec E
BMC Neurosci; 2006 Oct; 7():65. PubMed ID: 17014717
[TBL] [Abstract][Full Text] [Related]
20. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression.
Chung DW; Rudnicki DD; Yu L; Margolis RL
Hum Mol Genet; 2011 Sep; 20(17):3467-77. PubMed ID: 21672921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
